CRN responds to NYT article “Do You Need These Popular Supplements?”
CRN disputes the article’s portrayal of supplements as unnecessary for most Americans.
CRN disputes the article’s portrayal of supplements as unnecessary for most Americans.
Legislation reaffirms the FDA is the sole authority to regulate dietary supplements, reinforcing a single, national standard for ingredient safety and oversight.
New member applications are reviewed by CRN’s board of directors quarterly, with the next review scheduled for March.
The trade group said the updated guidelines balance prioritizing nutrient-dense foods and recognizing supplements as a science-based option to support public health.
The Council for Responsible Nutrition announced its 2026 Board of Directors as it gears up for increased regulation and legislation.
The Council for Responsible Nutrition commended the FDA for clarifying how companies can place the Dietary Supplement Health and Education Act disclaimer on labels.
CRN is asking the full Second Circuit to correct the panel’s decision
As the use of K2 supplements worldwide expanded, CRN conducted a review specifically focused on MK-7.
CRN emphasized that the ruling does not address the merits of its First Amendment claims.
CRN emphasized that the findings are preliminary, not peer-reviewed, and cannot establish cause and effect.
CRN has added new chapters on brain, eye, and heart-health nutrients to its Vitamin & Mineral Safety series, strengthening the scientific foundation for supplement safety.
Deshanie Rai, Ph.D., is vice president of global science, regulatory, and advocacy at OmniActive Health Technologies, and an adjunct professor at Tufts University.
“CRN welcomes these companies into our member community of dietary supplement and functional food industry leaders,” said CRN President and CEO Steve Mister.
After pushback on regulators’ interpretation of A.B. 899, lawmakers confirmed that dietary supplements are distinct from baby food and exempt from duplicative testing.
FDA declined to issue guidance or rulemaking, which CRN said will stifle innovation and perpetuate conflict between supplement makers and pharmaceutical companies.
A new CRN analysis shows that allowing dietary supplements under HSAs and FSAs would cost 75% less than previous estimates/